» Articles » PMID: 32547701

Panaxynol, a Bioactive Component of American Ginseng, Targets Macrophages and Suppresses Colitis in Mice

Abstract

Ulcerative colitis has a significant impact on the quality of life for the patients, and can substantially increase the risk of colon cancer in patients suffering long-term. Conventional treatments provide only modest relief paired with a high risk of side effects, while complementary and alternative medicines can offer safe and effective options. Over the past decade, we have shown that both American ginseng and its hexane fraction (HAG) have anti-oxidant and anti-inflammatory properties that can suppress mouse colitis and prevent colitis-associated colon cancer. With the goal of isolating a single active compound, we further fractionated HAG, and found the most abundant molecule in this fraction was the polyacetylene, panaxynol (PA). After isolating and characterizing PA, we tested the efficacy of PA in the treatment and prevention of colitis in mice and studied the mechanism of action. We demonstrate here that PA effectively treats colitis in a Dextran Sulfate Sodium mouse model by targeting macrophages for DNA damage and apoptosis. This study provides additional mechanistic evidence that American ginseng can be used for conventional treatment of colitis and other diseases associated with macrophage dysfunction.

Citing Articles

Antioxidant Therapy in Inflammatory Bowel Diseases: How Far Have We Come and How Close Are We?.

Xavier L, Reis T, da Paz Martins A, Santos J, Bueno N, Goulart M Antioxidants (Basel). 2024; 13(11).

PMID: 39594511 PMC: 11590966. DOI: 10.3390/antiox13111369.


Panaxynol improves crypt and mucosal architecture, suppresses colitis-enriched microbes, and alters the immune response to mitigate colitis.

Bullard B, McDonald S, Cardaci T, VanderVeen B, Mohammed A, Kubinak J Am J Physiol Gastrointest Liver Physiol. 2024; 326(5):G591-G606.

PMID: 38469632 PMC: 11376977. DOI: 10.1152/ajpgi.00004.2024.


Recent Insight into Herbal Bioactives-based Novel Approaches for Chronic Intestinal Inflammatory Disorders Therapy.

Harwansh R, Chauhan S, Deshmukh R, Mazumder R Curr Pharm Biotechnol. 2024; 25(14):1835-1857.

PMID: 38310453 DOI: 10.2174/0113892010282432231222060355.


The synthetic food dye, Red 40, causes DNA damage, causes colonic inflammation, and impacts the microbiome in mice.

Zhang Q, Chumanevich A, Nguyen I, Chumanevich A, Sartawi N, Hogan J Toxicol Rep. 2023; 11:221-232.

PMID: 37719200 PMC: 10502305. DOI: 10.1016/j.toxrep.2023.08.006.


Emerging Paradigms in Inflammatory Disease Management: Exploring Bioactive Compounds and the Gut Microbiota.

Benameur T, Porro C, Twfieg M, Benameur N, Panaro M, Filannino F Brain Sci. 2023; 13(8).

PMID: 37626582 PMC: 10452544. DOI: 10.3390/brainsci13081226.


References
1.
Hofseth L, Wargovich M . Inflammation, cancer, and targets of ginseng. J Nutr. 2006; 137(1 Suppl):183S-185S. DOI: 10.1093/jn/137.1.183S. View

2.
Yuan C, Wang X, Wu J, Attele A, Xie J, Gu M . Effects of Panax quinquefolius L. on brainstem neuronal activities: comparison between Wisconsin-cultivated and Illinois-cultivated roots. Phytomedicine. 2001; 8(3):178-83. DOI: 10.1078/0944-7113-00027. View

3.
Dieleman L, Palmen M, Akol H, Bloemena E, Pena A, Meuwissen S . Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998; 114(3):385-91. PMC: 1905133. DOI: 10.1046/j.1365-2249.1998.00728.x. View

4.
Roda G, Jharap B, Neeraj N, Colombel J . Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management. Clin Transl Gastroenterol. 2016; 7:e135. PMC: 4737871. DOI: 10.1038/ctg.2015.63. View

5.
Hofseth L, Ying L . Identifying and defusing weapons of mass inflammation in carcinogenesis. Biochim Biophys Acta. 2005; 1765(1):74-84. DOI: 10.1016/j.bbcan.2005.08.005. View